| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |